213 related articles for article (PubMed ID: 20058236)
1. Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer.
Calvo A; Perez-Stable C; Segura V; Catena R; Guruceaga E; Nguewa P; Blanco D; Parada L; Reiner T; Green JE
Prostate; 2010 May; 70(6):630-45. PubMed ID: 20058236
[TBL] [Abstract][Full Text] [Related]
2. Expression of a neuroendocrine gene signature in gastric tumor cells from CEA 424-SV40 large T antigen-transgenic mice depends on SV40 large T antigen.
Ihler F; Vetter EV; Pan J; Kammerer R; Debey-Pascher S; Schultze JL; Zimmermann W; Enders G
PLoS One; 2012; 7(1):e29846. PubMed ID: 22253802
[TBL] [Abstract][Full Text] [Related]
3. Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice.
Perez-Stable C; Altman NH; Brown J; Harbison M; Cray C; Roos BA
Lab Invest; 1996 Feb; 74(2):363-73. PubMed ID: 8780156
[TBL] [Abstract][Full Text] [Related]
4. Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
Deeb KK; Michalowska AM; Yoon CY; Krummey SM; Hoenerhoff MJ; Kavanaugh C; Li MC; Demayo FJ; Linnoila I; Deng CX; Lee EY; Medina D; Shih JH; Green JE
Cancer Res; 2007 Sep; 67(17):8065-80. PubMed ID: 17804718
[TBL] [Abstract][Full Text] [Related]
5. The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089.
Perez-Stable CM; Schwartz GG; Farinas A; Finegold M; Binderup L; Howard GA; Roos BA
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):555-63. PubMed ID: 12050097
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer progression, metastasis, and gene expression in transgenic mice.
Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA
Cancer Res; 1997 Mar; 57(5):900-6. PubMed ID: 9041192
[TBL] [Abstract][Full Text] [Related]
7. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
Lab Invest; 1998 Mar; 78(3):319-33. PubMed ID: 9520945
[TBL] [Abstract][Full Text] [Related]
8. Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice.
Reiner T; de Las Pozas A; Parrondo R; Perez-Stable C
Mol Cancer Res; 2007 Nov; 5(11):1171-9. PubMed ID: 17982114
[TBL] [Abstract][Full Text] [Related]
9. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
Lab Invest; 1998 Jun; 78(6):i-xv. PubMed ID: 9645768
[TBL] [Abstract][Full Text] [Related]
10. Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer.
Zhang J; Kim S; Li L; Kemp CJ; Jiang C; Lü J
Prostate; 2020 May; 80(7):588-605. PubMed ID: 32162714
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the transcriptome profiles related to globin gene switching during in vitro erythroid maturation.
Li B; Ding L; Li W; Story MD; Pace BS
BMC Genomics; 2012 Apr; 13():153. PubMed ID: 22537182
[TBL] [Abstract][Full Text] [Related]
12. Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg rat.
Wang Z; Luque RM; Kineman RD; Ray VH; Christov KT; Lantvit DD; Shirai T; Hedayat S; Unterman TG; Bosland MC; Prins GS; Swanson SM
Endocrinology; 2008 Mar; 149(3):1366-76. PubMed ID: 18079205
[TBL] [Abstract][Full Text] [Related]
13. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
[TBL] [Abstract][Full Text] [Related]
14. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
15. Regulation of γ-globin gene expression involves signaling through the p38 MAPK/CREB1 pathway.
Ramakrishnan V; Pace BS
Blood Cells Mol Dis; 2011 Jun; 47(1):12-22. PubMed ID: 21497119
[TBL] [Abstract][Full Text] [Related]
16. Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma.
Robinson C; Dick IM; Wise MJ; Holloway A; Diyagama D; Robinson BW; Creaney J; Lake RA
BMC Cancer; 2015 Dec; 15():983. PubMed ID: 26680231
[TBL] [Abstract][Full Text] [Related]
17. Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.
Morgenbesser SD; McLaren RP; Richards B; Zhang M; Akmaev VR; Winter SF; Mineva ND; Kaplan-Lefko PJ; Foster BA; Cook BP; Dufault MR; Cao X; Wang CJ; Teicher BA; Klinger KW; Greenberg NM; Madden SL
Prostate; 2007 Jan; 67(1):83-106. PubMed ID: 17013881
[TBL] [Abstract][Full Text] [Related]
18. Metastatic prostate cancer in a transgenic mouse.
Gingrich JR; Barrios RJ; Morton RA; Boyce BF; DeMayo FJ; Finegold MJ; Angelopoulou R; Rosen JM; Greenberg NM
Cancer Res; 1996 Sep; 56(18):4096-102. PubMed ID: 8797572
[TBL] [Abstract][Full Text] [Related]
19. Sequential combinations of flavopiridol and docetaxel inhibit prostate tumors, induce apoptosis, and decrease angiogenesis in the Ggamma/T-15 transgenic mouse model of prostate cancer.
Reiner T; de las Pozas A; Perez-Stable C
Prostate; 2006 Oct; 66(14):1487-97. PubMed ID: 16921509
[TBL] [Abstract][Full Text] [Related]
20. An in vivo model for analysis of developmental erythropoiesis and globin gene regulation.
McColl B; Kao BR; Lourthai P; Chan K; Wardan H; Roosjen M; Delagneau O; Gearing LJ; Blewitt ME; Svasti S; Fucharoen S; Vadolas J
FASEB J; 2014 May; 28(5):2306-17. PubMed ID: 24443374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
